{"disease":{"id":"hematological-malignancy","name":"hematological malignancy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06224452","title":"Is Ibrutinib-related Atrial Fibrillation Dose Dependent","phase":"","overall_status":"UNKNOWN","enrollment_count":18000,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT05467449","title":"DxFLEX 10C Clinical Study","phase":"","overall_status":"COMPLETED","enrollment_count":527,"lead_sponsor_name":"Beckman Coulter, Inc.","has_results":false},{"nct_id":"NCT03960593","title":"Cohort of Patients Over 70 Years of Age With Cancer and / or Hematological Malignancy","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Assistance Publique Hopitaux De Marseille","has_results":false},{"nct_id":"NCT01084252","title":"Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":351,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05255926","title":"CXCR4-targeted PET/CT Imaging in Hematological Malignancies","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT05784870","title":"A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":168,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT04613765","title":"A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting","phase":"","overall_status":"UNKNOWN","enrollment_count":113,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT06106360","title":"A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Inova Health Care Services","has_results":false},{"nct_id":"NCT06225856","title":"An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":96,"lead_sponsor_name":"Shanghai Yuyao Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT04932967","title":"Use of nMoABs for the Treatment of COVID-19 in Patients With HM.","phase":"","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Gruppo Italiano Malattie EMatologiche dell'Adulto","has_results":false},{"nct_id":"NCT03649334","title":"Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Mansoura University","has_results":false},{"nct_id":"NCT07462962","title":"Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Henan University","has_results":false},{"nct_id":"NCT05895357","title":"The Effect of Music Therapy on Comfort, Pain and Anxiety","phase":"NA","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Izmir Bakircay University","has_results":false},{"nct_id":"NCT05110742","title":"Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":64,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05510089","title":"Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies","phase":"NA","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"The Affiliated People's Hospital of Ningbo University","has_results":false},{"nct_id":"NCT04684108","title":"SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":61,"lead_sponsor_name":"Hangzhou Sumgen Biotech Co., Ltd.","has_results":false},{"nct_id":"NCT06758713","title":"Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"The Third Affiliated Hospital of Southern Medical University","has_results":false},{"nct_id":"NCT04841447","title":"Membrane Target Detection for Leukemia Treatment","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Missouri-Columbia","has_results":false},{"nct_id":"NCT06584006","title":"Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT03241550","title":"A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT06948981","title":"GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT03806712","title":"Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)","phase":"","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT04347226","title":"Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT03159702","title":"Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Medical College of Wisconsin","has_results":true},{"nct_id":"NCT05364359","title":"Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Copenhagen","has_results":false},{"nct_id":"NCT06586671","title":"A Study to Compare Forms of Nemtabrutinib (MK-1026) in Healthy Adult Participants (MK-1026-007)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03611764","title":"Body Scan Activity on Bone Marrow Transplant Patients and Their Caregivers","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":37,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT07066592","title":"Investigation of the Effects of Prehabilitation Education Delivered Through a Mobile Compatible Website on Quality of Life and Symptoms in Patients Undergoing Hematopoietic Stem Cell Transplantation","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT04305249","title":"Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":36,"lead_sponsor_name":"Antengene Therapeutics Limited","has_results":false},{"nct_id":"NCT04884204","title":"Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05391022","title":"Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Constellation Pharmaceuticals","has_results":false},{"nct_id":"NCT07131254","title":"A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"Grit Biotechnology","has_results":false},{"nct_id":"NCT06238336","title":"Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Shanxi Bethune Hospital","has_results":false},{"nct_id":"NCT04103879","title":"US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"ExCellThera inc.","has_results":false},{"nct_id":"NCT07145359","title":"Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Halic University","has_results":false},{"nct_id":"NCT04082910","title":"Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06066255","title":"PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":27,"lead_sponsor_name":"Institut Paoli-Calmettes","has_results":false},{"nct_id":"NCT04287309","title":"CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT04687982","title":"Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002).","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Istituto Clinico Humanitas","has_results":false},{"nct_id":"NCT03850366","title":"HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Henry Ford Health System","has_results":false},{"nct_id":"NCT03885947","title":"VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Alla Keyzner","has_results":false},{"nct_id":"NCT04093622","title":"Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy","phase":"","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Fate Therapeutics","has_results":false},{"nct_id":"NCT05293912","title":"SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Hangzhou Sumgen Biotech Co., Ltd.","has_results":false}],"total":43},"guidelines":[],"source":"Drug Landscape verified database"}